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Objective.Toevaluatethemanagementandoutcomesofaseriesofhumanimmunodeﬁciencyvirus-(HIV-)infectedwomenwhose
pregnancies were complicated by preterm premature rupture of membranes (PPROM). Study design. We conducted a retrospec-
tive chart review of all women with conﬁrmed HIV infection who had a pregnancy complicated by PPROM remote from term.
PPROM remote from term was deﬁned as rupture of membranes prior to 32-week gestation. Collective cases from two centers
(Hennepin County Medical Center and The University of Alabama at Birmingham) were reviewed and data on management and
outcomeswereabstracted.Results.OftheHIV-positivewomen,weidentiﬁed291pregnancieshavingoccurredinthestudyinterval
from two institutions. Of these pregnancies, 7 (2.4%) developed PPROM remote from term with subsequent delivery from 25- to
32-week gestation. Vertical HIV transmission was noted in 2 of 6 children whose long-term followup status was conﬁrmed (33%)
of these cases. However, both of these cases occurred in women with either no antepartum/intrapartum antiviral therapy or where
only zidovudine monotherapy was used. Importantly, in spite of expectant management, no cases of vertical HIV transmission
occurred in women who were receiving either multidrug or highly active antiviral therapy (HAART) at the time of PPROM and
who had a cesarean delivery in cases where the predelivery viral load > 1000copies/mL. Conclusion. Our limited observations raise
the question as to whether in the current era of multidrug therapy immediate delivery should be undertaken in HIV+ pregnancies
complicated by PPROM at an early gestational age. This case series further suggests that in those pregnancies that lend themselves
to expectant management, such a strategy may be considered appropriate.
Copyright © 2006 Kjersti M. Aagaard-Tillery et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
INTRODUCTION
Preterm premature rupture of membranes (PPROM) oc-
curs in approximately 3% of all pregnancies, accounting for
nearly 1/3 of all preterm births [1–5]. Moreover, PPROM
is a contributor to perinatal morbidity and mortality—
primarily due to its association with delivery remote from
term, chorioamnionitis, placental abruption, and umbilical
cord compression or prolapse [1, 2].
Management of women with HIV infection who develop
PPROM poses an obstetric dilemma. Limited data are avail-
able to direct optimal management of HIV-positive women
who develop PPROM. Previous investigations have demon-
strated that in term pregnancies complicated by maternal
HIV infection, duration of membrane rupture >4h o u r s
increases the risk of intrapartum vertical transmission [12–
17]. By extrapolation of this data, some authors suggest that
women with HIV who undergo PPROM should not be man-
aged conservatively [1, 12–14]. However, in instances near
the limits of viability, conservative management of PPROM
may be justiﬁed because of the extremely high risk of mor-
tality and chronic morbidity when immediate delivery is
prompted [1]. We and others [1] have been unable to iden-
tify any published manuscripts to date reporting on conser-
vative management of PPROM in the setting of HIV (Med-
line search 1 January 1966–1 September 2005: search terms:
preterm premature rupture of membranes, human immun-
odeﬁciency virus infection, acquired immunodeﬁciency syn-
drome). Given an absolute lack of published reports, we
sought to provide an initial report on the management and2 Infectious Diseases in Obstetrics and Gynecology
outcomes of a series of HIV-infected women whose preg-
nancies were complicated by preterm premature rupture of
membranes (PPROM).
MATERIALS AND METHODS
Discussionofmanagementoptions
In each instance, a thorough and complete review of the rel-
ative risks of prematurity and PPROM remote from term
and potential for vertical transmission with prolonged rup-
ture of the membranes was reviewed with the patient, and
documented in the patient chart. These discussions involved
obstetrician/gynecologists, maternal-fetal medicine special-
ists,neonatologists,and/orinfectiousdiseasespecialists,with
language interpreters as indicated.
Studypopulation
At Hennepin County Medical Center (HCMC), the HIV-
infected women were identiﬁed through the HCMC HIV
database encompassing the interval from 1990 to 2004, and
the electronic medical records (EMRs) system was reviewed
to identify whether they had been seen through the obstet-
rics and gynecology clinics, high-risk obstetrics clinics, or on
labor and delivery. For those with identiﬁed encounters, ex-
haustive review of both the EMR and patient chart was un-
dertakentoascertainwhetherapregnancyhadoccurred,and
whether the pregnancy had been complicated by PPROM
remote from term. At The University of Alabama at Birm-
ingham (UAB), an electronic obstetric database (OBAR) of
women who obtained their prenatal care and delivered at
UABfrom1980to2004wassearched.WomenwithHIVhav-
ing undergone PROM were identiﬁed and for those women
in whom latency was greater than 24 hours, an exhaustive
chart review was performed.
Deﬁnitions
PPROM remote from term was deﬁned as preterm, prema-
ture rupture of the membranes prior to 32-week gestation
conﬁrmed by ferning, pooling, or indigo-carmine amnioin-
fusion;dating wasbypreviouslypublished AmericanCollege
of Obstetricians and Gynecologist (ACOG) criteria and em-
ployed last menstrual period with fetal biometry by ultra-
sonographic determination [22]. Maternal HIV-positive sta-
tus was deﬁned as documentation of HIV-1 or HIV-2 sero-
conversion, conﬁrmed by Western blot analysis. AIDS was
deﬁned as an absolute CD4+, CD3+ lymphocyte count less
than200×106 cells/L.Infantswereconsideredinfectedifthey
were HIV-seropositive, conﬁrmed by Western blot at >18
months of age, had two or more positive PCR tests or viral
cultures at any age, had an AIDS-deﬁning illness, or if they
died with an HIV-related condition.
Dataextraction
Once a pregnancy was identiﬁed as having been dually com-
plicated by HIV-positive maternal status and PROM remote
from term, data was uniformly extracted from the patients
chart with respect to maternal characteristics (age, ethnicity,
parity, year of HIV-positive diagnosis, past medical history,
polysubstance abuse history, and infectious comorbidities),
prenatal care (gestational age and dating criteria, gestational
age at initiation of prenatal care, gestational age at initiation
of HAART/therapy, number of prenatal visits), HIV char-
acteristics (genotype, AIDS, infectious comorbidities [GBS,
trichomonas, gonorrhea, Chlamydia, PPD, Hepatitis A, B, or
C]), PPROM characteristics (means of conﬁrmation, most
recent viral load and CD4 count prior to PPROM, antiviral
therapy at PPROM, gestational age at delivery, latency inter-
val, indication for delivery, clinical or histologic evidence of
chorioamnionitis), use of antiviral and antimicrobial ther-
apy (HAART/intrapartum AZT, duration of use, utilization
of antibiotics for the prolongation of latency), maternal peri-
partumcomplications(sepsis,chorioamnionitis, endometri-
tis), and fetal and infant characteristics (administration of
steroids for the promotion of fetal lung maturity, infant sex,
birth weight, APGARS, cord gasses, NICU admission and
duration of NICU stay, neonatal sepsis, RDS, IVH, necrotiz-
ing enterocolitis, vertical transmission, other complications
or medical morbidities).
IRBapproval
At HCMC, the HIV database for women with HIV is sup-
ported by Infectious Disease HIV Clinic with IRB approval.
As this represented a case series, no further IRB approval was
deemed necessary. At UAB, expedited IRB approval was ob-
tained for chart review and data extraction.
RESULTS
Patientcharacteristics(Table 1)
Over the indicated study intervals at HCMC and UAB, Birm-
ingham, we identiﬁed 291 pregnancies having occurred in
the cohort of HIV-positive women. Of these pregnancies, 7
(2.4%) developed PPROM with subsequent delivery from
25-to 32-week gestation. With the exception of one patient
(patient 1), all women received prenatal care in their ﬁrst or
early midtrimester. For those who received adequate prena-
tal care, medical comorbidities reported reﬂect those found
in the at-large HCMC and UAB populations.
HIVandinfectiousmorbidity(Table 2)
With the exception of two patients (patients 2 and 6), all
women were aware of their diagnosis of HIV prior to the
pregnancy. Note that the diagnosis of HIV seroconversion
( f o rp a t i e n t1 )o c c u r r e di nap r i o rp r e g n a n c y ,b u tt r e a t m e n t
was never initiated secondary to failed followup; this was
in spite of multiple attempts to encourage compliance with
care.
Each of the patients who received prenatal care at HCMC
was initiated on HAART in the early midtrimester; two of
these patients continued a modiﬁcation of their prepreg-
nancy therapy (Table 2). At UAB, both pregnancies oc-
curred (1993) prior to the use of HAART in pregnancy. One
woman (patient 6) was part of the PACTG 076 trial and wasKjersti M. Aagaard-Tillery et al 3
Table 1: Patient characteristics on admission. PNC: prenatal care; ARDS: adult respiratory distress syndrome; AZT: zidovudine; AIDS:
acquired immunodeﬁciency syndrome; N/A: data not available.
Patient Age
(years) Parity Ethnicity
Gestational age
at initiation of
prenatal care
Medical
comorbidities
Substance
abuse
HIV diagnosis
in pregnancy
Duration of
HIV infection
(years)
AIDS
1 24 2103 African
American
No PNC prior
to admission
Polysubstance
abuse
Yes
(cocaine) No 1 No
2 25 1001 Caucasian 13 0/7 Polysubstance
abuse
Yes
(cocaine) Yes 0 No
3 30 5013 African 15 3/7
History of
neutropenic sepsis
with ARDS
secondary to AZT
therapy
No No 3 No
4 30 1001 Latino 5 2/7
Chronic pain
Anxiety
Appendicitis
(21-week gestation)
No No 11 No
5 33 2012 Native
American 70 / 7 Remote history of
pyelonephritis
Yes
(marijuana
alcohol)
No 7 No
6 19 0211 African-
American 9 2/7 None No Yes 0 No
7 29 1021 African-
American 72 / 7
Laparotomy
(trauma),
appendectomy,
pneumonia,
Hepatitis C, history
of syphilis
Yes
(cocaine,
alcohol,
tobacco)
No 0 No
randomized to placebo. The second patient was receiving
AZT prepregnancy and continued this regimen antepartum.
All patients were screened for viral and bacterial in-
fectious comorbidities on initial presentation; all were re-
screened on admission. None were Hepatitis B surface
antigen-positive, one was Hepatitis C positive (patient 7);
one (patient 3) had been previously exposed to Hepatitis
A but was without active disease. Three of the 7 patients
had Trichomonas vaginalis detected and treated, and one
woman (patient 1) was positive and treated for Trichomonas,
Ct r a c h o m a t i s ,a n dN gonorrhea at the time of admission.
All women were RPR nonreactive on admission (data not
shown). Two women (patients 3 and 7) had a history of tu-
berculosis, and had previously received therapy accordingly.
PPROManddeliverycharacteristics(Table 3)
Each patient in our series was distinct from the others with
respecttogestationalageatthetimeofPPROM;however,the
overall proﬁle typiﬁes that seen among HIV-negative women
with PPROM. In one instance (patient 2), PPROM occurred
prior to viability and extensive counseling regarding the risks
ofoligohydramniosandprolongedrupturedmembraneswas
undertaken. The patient elected to pursue expectant man-
agement.
With respect to viral load at the time of PPROM, one
woman (patient 1) was hospitalized for preterm labor when
rupture of membranes occurred. With respect to patients 2
and 5, noncompliance with outpatient HAART was prob-
lematic prior to PPROM. However, with inpatient manage-
ment (patient 5) and frequent outpatient visits (patient 2),
complianceimprovedandtheviralloaddeclinedaccordingly
(Table 3). As per protocol standard at the time of presenta-
tion, viral loads were not obtained in the women that deliv-
ered at UAB.
All patients with ongoing pregnancies at HCMC received
intravenous AZT for a maximum of 48 hours following
membrane rupture, with repeat administration of therapy
proximal to delivery. During the same interval, HAART was
utilized as per their antepartum regimen (Table 3). The sin-
gle exception to optimal utilization of intrapartum AZT use
was patient 3, as she had experienced a prior episode of neu-
tropenic sepsis with ARDS. At UAB, intrapartum AZT was
not administered to one woman (patient 6) as per study
(PACTG 076) protocol following randomization to placebo.
In another patient, intravenous AZT was administered for
60hours during her prolonged latent phase (from the time
of admission to the time of delivery).
The mean latency in this cohort was 17.1d a y sw i t ha
median of 5 days; one woman (patient 2) had a latency of
92 days. Indications for delivery typiﬁed that of pregnancies
complicated by PPROM, and mode of delivery was deter-
mined by obstetrical indications (Table 3).4 Infectious Diseases in Obstetrics and Gynecology
Table 2:HIVandinfectiousmorbidity.HIV:humanimmunodeﬁciencyvirus;AIDS:acquiredimmunodeﬁciencysyndrome;HAART:highly
active antiretroviral therapy; AZT: zidovudine; INH: isoniazide; PACTG: the Pediatric AIDS Clinical Trials Group; TB: tuberculosis; S/P:
status-post.
Patient Prepregnancy
therapy
Initial
viral load
(copies/mL)
Initial
CD4 count
(abs/mm3)
Gestational
age at
initiation
of HAART
Antepartum
therapy
Vaginal
infections
in this
pregnancy
Viral
coinfections PPD status
1 None 2672 508 None AZT
Trichomonas
Ct r a c h o m a t i s
Gonorrhea
None Negative
2 None 179 858 15 0/7 Combivir
Neviripine None None Negative
3
Neviripine
Lamivudine
Stavudine
<50 684 15 3/7
Neviripine
Lamivudine
Stavudine
None Hepatitis A
Positive, s/p
INH
prophylaxis
4 Combivir <50 407 13 0/7 Combivir
Neviripine None None Negative
5 None 971 312 14 0/7 Combivir Trichomonas None Negative
6 None N/A 766 None
(Placebo
arm of
PACTG
076)
None None Negative
7 AZT N/A N/A None AZT Trichomonas Hepatitis C h/o TB, s/p
therapy
Maternalcomplications(Table 3)
Clinical or histologic evidence of chorioamnionitis was
prevalent; endometritis ensued in four cases. There was one
instance of maternal sepsis with positive blood cultures for
Peptostreptococcus. Otherwise, the duration of postdelivery
hospitalization mirrored that of the general obstetric pop-
ulation at the respective institutions.
Infantsequelaeandcomplications(Table 4)
Neonatal outcomes of the pregnancies in our series are
shown in Table 4. Vertical HIV transmission was noted in 2
of the possible 6 cases (33%). In the two instances of ver-
tical transmission, one woman and infant pair received no
antiretroviral therapy as per study (PACTG 076) protocol.
In the second instance, AZT was the only antiretroviral em-
ployed and viral loads were not used to guide delivery prac-
tice. All infants (except for patient 6 (PACTG 076 proto-
col)) received antiretroviral therapy in the neonatal period
as per standard of care. Of the cases without vertical trans-
mission in our series, all women received HAART at the time
of PPROM with cesarean delivery for those with a viral load
>1000copies/mL.
COMMENTS
In our series, there were no instances of vertical transmis-
sion in women with PPROM who were receiving multidrug
therapy or HAART despite prolonged intervals of rupture
of membranes. The only two cases of vertical transmission
observed were in one woman who did not receive antepar-
tum or intrapartum antiretroviral therapy, and in another
whoreceivedonlyAZTintheantepartumperiod.Ourobser-
vationssuggestthatintheeraofHAART,onemightconsider
whether or not immediate delivery should be undertaken in
pregnancies complicated by PPROM at an early gestational
age. Alternatively, in pregnancies that may lend themselves
to expectant management, such a strategy should be enter-
tained.
In pregnancies complicated by maternal HIV infection,
duration of rupture of membranes >4h o u r s ,i nt e r mp r e g -
nancies appear to increase the risk of intrapartum vertical
transmission [12–17]. In one study [19], prolonged rup-
ture of membranes in term (>37 weeks) relative to preterm
(<37 weeks) was assessed. The authors found a 3.8-fold
RR (95% CI 1.9,7.8) increase in intrapartum HIV trans-
mission when comparing preterm to term infants whose
membranes had been ruptured >4 hours. These authors at-
tempted to delineate whether vertical transmission occurred
in the intrauterine or intrapartum period and came to the
conclusion that “preterm infants are at increased risk of
acquiring infection at the time of delivery,” see [19]. How-
ever, transmission risk was not stratiﬁed by use of antiretro-
viral therapy, gestational age, nor mode of delivery [19]. As
with this study, other studies [12–17] exploring the relation-
ship of duration of membrane rupture and perinatal HIV
transmission have failed to account for the use of HAART
and viral load at the time of delivery.
One recent analysis [23] investigated the risk of perina-
tal HIV transmission in women on combination antiretrovi-Kjersti M. Aagaard-Tillery et al 5
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Table 4: Infant sequelae and complications. N/A: not assessable, secondary to intrauterine fetal death. NICU: neonatal intensive care unit;
RDS: respiratory distress syndrome; IVH: intraventricular hemorrhage; NEC: necrotizing enterocolitis; IUFD: intrauterine fetal demise;
VSD: ventriculoseptal defect.
Patient
Delivery
gestational
age (weeks)
Infant
gender
Birth weight
(g)
Apgars
(1,5m)
NICU
admission
(days)
Antenatal
steroids
Neonatal
complications
Vertical
transmission
1 31 5/7 Male 1660 6, 9 29 Yes RDS No
2 30 2/7 Female 710 0, 0 IUFD Yes IUFD N/A
3 31 0/7 Male 1360 6, 7 53 Yes None No
4 31 6/7 Female 2000 9, 9 7 Yes None No
5 25 5/7 Male 778 3, 3 148 Yes
RDS, pyloric
stenosis, VSD,
retinopathy of
prematurity,
fetal alcohol
syndrome
No
6 31 3/7 Male 1605 5, 8 29 No RDS,
neutropenia Yes
7 24 4/7 Male 827 1, 7 60 No RDS, IVH
grade 1, anemia Yes
raltherapywithviralloads<1000copies/mL and membrane
rupture >4h o u r s .D u r a t i o no fm e m b r a n er u p t u r ew a sn o ta
risk factor for vertical transmission. Interestingly, monother-
apy (OR 6.3, CI 2.4–16.6) or lack of antiretroviral therapy
(OR 17.4, CI 6.7–45.5) and viral load >1000copies/mL (OR
9.9, CI 1.2–84.5) were independently associated with neona-
tal infection. Our case series suggests that this relationship
between combination antiretroviral therapy and reduction
in the rate of vertical transmission may apply to pregnan-
cies complicated by prolonged premature preterm rupture of
membranes and HIV.
We recognize that the primary limitation of this study is
itslimitedsamplesizeanditsheterogeneouspopulation.Our
seriesdoesnotclaimtoprovideanystatisticalriskassessment
forcounselingpatientsontherelativemeritsorrisksoftrans-
mission in the setting of PPROM remote from term. Rather,
it is our hope that this novel series will provide an impetus to
further reports and larger multi-institutional investigations
to address this important clinical issue.
CONDENSATION
We report a novel case series describing management and
outcomes in human immunodeﬁciency virus-infected wo-
men who developed preterm premature rupture of mem-
branes remote from term.
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